JD Supra

Foreign Drug and Medical Device Manufacturers Under a Second Trump Administration: Increased Enforcement Scrutiny?

As discussions intensify about how the second Trump administration will reshape the regulatory landscape for U.S.-based life sciences firms, less attention has been given to the new administration’s ...
JD Supra

From Offshore to Onshore: Considerations for Pharmaceutical Industry Stakeholders Amid New Domestic Drug Manufacturing EO

The White House on May 5, 2025 issued an executive order requiring the US Food and Drug Administration to find ways to facilitate the opening of new drug manufacturing sites in the United States while ...
RAPS

As FDA resumes foreign inspections, GAO recommends revamping the program

In a report published Monday, the Government Accountability Office (GAO) raises questions about the US Food and Drug Administration’s (FDA) foreign inspections program for drugs and says the program ...
Forbes

From Production To Precision: How AI Is Reshaping Manufacturing

Manufacturing is getting a lot more attention in the news recently. While globalization has pushed the availability of goods around the world and lowered their cost in significant ways over these past ...